Inogen Announces Third Quarter 2026 Financial Results
Business Wire•05/11/2026•16:05 ET
0
Key Highlights
- ➤Q3 revenue $77.2 million, down 2.4% year over year
- ➤Q3 GAAP loss $14.8 million versus $3.6 million loss previously
- ➤Full-year revenue guidance $298 million to $301 million
- ➤Cost reduction program targets approximately $20 million annualized savings by end-2027
- ➤Oxygen rental divestiture completed for estimated cash consideration up to $24.8 million
Expert Statements
Andy Reding, President and Chief Executive Officer of Inogen
“I am excited to lead Inogen at an important inflection in the Company’s evolution”
Andy Reding, President and Chief Executive Officer of Inogen
“We have a strong foundation, including a talented team, a differentiated portfolio of respiratory solutions, and deep customer relationships.”
Andy Reding, President and Chief Executive Officer of Inogen
“At the same time, we have meaningful opportunities to sharpen our focus, strengthen execution, and improve commercial and operational performance.”
Andy Reding, President and Chief Executive Officer of Inogen
“We remain focused on building a simpler, more focused company that can deliver sustainable, profitable growth and create long-term value for our shareholders.”
Board of Directors appoints Andy Reding as President and Chief Executive Officer
Company initiates a $20 million cost reduction program to accelerate profitability
Get started
Create a free account to read the full story.